Literature DB >> 15044090

Induction of endogenous glutathione by the chemoprotective agent, 3H-1,2-dithiole-3-thione, in human neuroblastoma SH-SY5Y cells affords protection against peroxynitrite-induced cytotoxicity.

Zhuoxiao Cao1, Seema Hallur, Harry Z Qiu, Xingxiang Peng, Yunbo Li.   

Abstract

Substantial evidence suggests that peroxynitrite generated from the bi-radical reaction of nitric oxide and superoxide is critically involved in the pathogenesis of neurodegenerative disorders, such as Parkinson's disease. Reaction with sulfhydryl (SH)-containing molecules has been proposed to be a major detoxification pathway of peroxynitrite in biological systems. This study was undertaken to determine if chemically elevated intracellular reduced glutathione (GSH), a major SH-containing biomolecule, affords protection against peroxynitrite-mediated toxicity in cultured neuronal cells. Incubation of human neuroblastoma SH-SY5Y cells with the unique chemoprotectant, 3H-1,2-dithiole-3-thione (D3T), led to a significant elevation of cellular GSH in a concentration-dependent fashion. To examine the protective effects of D3T-induced GSH on peroxynitrite-mediated toxicity, SH-SY5Y cells were pretreated with D3T and then exposed to either the peroxynitrite generator, 3-morpholinosydnonimine (SIN-1), or the authentic peroxynitrite. We observed that D3T-pretreated cells showed a markedly increased resistance to SIN-1- or authentic peroxynitrite-induced cytotoxicity, as assessed by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium reduction assay. Conversely, depletion of cellular GSH by buthionine sulfoximine (BSO) caused a marked potentiation of SIN-1- or authentic peroxynitrite-mediated cytotoxicity. To further demonstrate the causal role for GSH induction in D3T-mediated cytoprotection, SH-SY5Y cells were co-treated with BSO to abolish D3T-induced GSH elevation. Co-treatment of the cells with BSO was found to significantly reverse the protective effects of D3T on SIN-1- or authentic peroxynitrite-elicited cytotoxicity. Taken together, this study demonstrates for the first time that D3T can induce GSH in cultured SH-SY5Y cells, and that the D3T-augmented cellular GSH defense affords a marked protection against peroxynitrite-induced toxicity in cultured human neuronal cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044090     DOI: 10.1016/j.bbrc.2004.02.156

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Effect of glutathione redox state on Leydig cell susceptibility to acute oxidative stress.

Authors:  Haolin Chen; Liang Zhou; Chieh-Yin Lin; Matthew C Beattie; June Liu; Barry R Zirkin
Journal:  Mol Cell Endocrinol       Date:  2010-03-03       Impact factor: 4.102

2.  Succinobucol, a Lipid-Lowering Drug, Protects Against 3-Nitropropionic Acid-Induced Mitochondrial Dysfunction and Oxidative Stress in SH-SY5Y Cells via Upregulation of Glutathione Levels and Glutamate Cysteine Ligase Activity.

Authors:  Dirleise Colle; Danúbia Bonfanti Santos; Juliana Montagna Hartwig; Marcelo Godoi; Daiane Fátima Engel; Andreza Fabro de Bem; Antonio L Braga; Marcelo Farina
Journal:  Mol Neurobiol       Date:  2015-01-27       Impact factor: 5.590

3.  The neuroprotective potential of phase II enzyme inducer on motor neuron survival in traumatic spinal cord injury in vitro.

Authors:  Xiao-Yun Liu; Chun-Yan Li; Hui Bu; Zhe Li; Bin Li; Meng-Meng Sun; Yan-Su Guo; Li Zhang; Wen-Bo Ren; Zhi-Liang Fan; Dong-Xia Wu; Shu-Yu Wu
Journal:  Cell Mol Neurobiol       Date:  2007-10-03       Impact factor: 5.046

4.  Potent upregulation of glutathione and NAD(P)H:quinone oxidoreductase 1 by alpha-lipoic acid in human neuroblastoma SH-SY5Y cells: protection against neurotoxicant-elicited cytotoxicity.

Authors:  Zhenquan Jia; Seema Hallur; Hong Zhu; Yunbo Li; Hara P Misra
Journal:  Neurochem Res       Date:  2007-10-17       Impact factor: 3.996

5.  Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism.

Authors:  S Jill James; Shannon Rose; Stepan Melnyk; Stefanie Jernigan; Sarah Blossom; Oleksandra Pavliv; David W Gaylor
Journal:  FASEB J       Date:  2009-03-23       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.